The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNAAng1+Vegf nanoparticles

Biomaterials

Volumn 33, Issue 30, 2012, Pages 7655-7664

  Paul, Arghya ^a   Shao, Wei ^a   Shum Tim, Dominique ^b   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Endothelium; Hydrogel; Nanoparticles; Restenosis; Stent

Indexed keywords

ALTERNATE LAYERS; BIOMEDICAL DEVICES; BIOTHERAPEUTICS; CONTROLLED DELIVERY; ENDOTHELIUM; ENDOVASCULAR; FEMORAL ARTERY; FIBRIN MATRIX; HISTOMORPHOMETRIC ANALYSIS; HYDROGEL LAYERS; IN-STENT RESTENOSIS; IN-VITRO; IN-VIVO EXPERIMENTS; LAYER-BY-LAYERS; NEOINTIMA FORMATION; POLYACRYLIC ACIDS; RESTENOSIS; SITE-SPECIFIC; STENT; TARGET SITES; TAT PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

DISEASES; GENE TRANSFER; GENES; HYDROGELS; NANOPARTICLES; ORGANIC ACIDS; SINGLE-WALLED CARBON NANOTUBES (SWCN);

STENTS;

ANGIOPOIETIN 1; DNA; FIBRIN; NANOPARTICLE; POLYACRYLIC ACID; SINGLE WALLED NANOTUBE; TRANSACTIVATOR PROTEIN; VASCULOTROPIN;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ACTIVITY; FEMORAL ARTERY; GENE TRANSFER; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; IN-STENT RESTENOSIS; MORPHOMETRICS; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANGIOPOIETIN-1; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; DNA; DOGS; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; GENE TRANSFER TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEL; NANOPARTICLES; NANOTUBES, CARBON; RECOVERY OF FUNCTION; STENTS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864980356     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.096     Document Type: Article

References (41)

1. Lloyd-Jones D., Adams R., Carnethon M., de Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics-2009-update - a report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2009, 120(24):E2-E220.
2. Michaels A.D., Chatterjee K. Angioplasty versus bypass surgery for coronary artery disease. Circulation 2002, 106(23):E187-E190.
3. Bauters C., Isner J.M. The biology of restenosis. Prog Cardiovasc Dis 1997, 40(2):107-116.
4. Hiltunen M.O., Laitinen M., Turunen M.P., Jeltsch M., Hartikainen J., Rissanen T.T., et al. Intravascular adenovirus-mediated vegf-c gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2000, 102(18):2262-2268.
5. Shuchman M. Debating the risks of drug-eluting stents. New Engl J Med 2007, 356(4):325-328.
6. Serruys P.W., Kutryk M.J.B., Ong A.T.L. Drug therapy - coronary-artery stents. New Engl J Med 2006, 354(5):483-495.
7. Martinez A.W., Chaikof E.L. Microfabrication and nanotechnology in stent design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3(3):256-268.
8. Brito L., Amiji M. Nanoparticulate carriers for the treatment of coronary restenosis. Intl J Nanomed 2007, 2(2):143-161.
9. Paul A., Abbasi S., Shum-Tim D., Prakash S. Nano- and biotechnological approaches in current and future generation of cardiovascular stents. Curr Nanosci 2010, 6(5):469-478.
10. Sharif F., Hynes S.O., Cooney R., Howard L., McMahon J., Daly K., et al. Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 2008, 16(10):1674-1680.
11. Perlstein I., Connolly J.M., Cui X., Song C., Li Q., Jones P.L., et al. Dna delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection. Gene Ther 2003, 10(17):1420-1428.
12. Sharif F., Hynes S.O., McMahon J., Cooney R., Conroy S., Dockery P., et al. Gene-eluting stents: comparison of adenoviral and adeno- associated viral gene delivery to the blood vessel wall in vivo. Hum Gene Ther 2006, 17(7).
13. Zhu D.W., Jin X., Leng X.G., Wang H., Bao J.B., Liu W.G., et al. Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid dna nanoparticles. Intl J Nanomed 2010, 5:1095-1102.
14. Dincer S., Turk M., Piskin E. Intelligent polymers as nonviral vectors. Gene Ther 2005, 12:S139-S145.
15. Gao X., Kim K.S., Liu D.X. Nonviral gene delivery: what we know and what is next. AAPS J 2007, 9(1):E92-E104.
16. Hedman M., Hartikainen J., Yla-Herttuala S. Progress and prospects: hurdles to cardiovascular gene therapy clinical trials. Gene Ther 2011, 18(8):743-749.
17. Shin S.R., Bae H., Cha J.M., Mun J.Y., Chen Y.C., Tekin H., et al. Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano 2012, 6(1):362-372.
18. Brammer K.S., Oh S.H., Gallagher J.O., Jin S.H. Enhanced cellular mobility guided by TiO(2) nanotube surfaces. Nano Lett 2008, 8(3):786-793.
19. Fine E., Zhang L.J., Fenniri H., Webster T.J. Enhanced endothelial cell functions on rosette nanotube-coated titanium vascular stents. Intl J Nanomed 2009, 4(1):91-97.
20. Prakash S., Malhotra M., Shao W., Tomaro-Duchesneau C., Abbasi S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliver Rev 2011, 63(14, 15):1340-1351.
21. Paul A., Binsalamah Z.M., Khan A.A., Abbasia S., Elias C.B., Shum-Tim D., et al. A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials 2011, 32(32):8304-8318.
22. Stout D.A., Basu B., Webster T.J. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater 2011, 7(8):3101-3112.
23. Dvir T., Timko B.P., Brigham M.D., Naik S.R., Karajanagi S.S., Levy O., et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol 2011, 6(11):720-725.
24. Paul A., Nayan M., Khan A.A., Shum-Tim D., Prakash S. Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. Int J Nanomedicine 2012, 7:663-682.
25. Lo S.L., Wang S. An endosomolytic tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008, 29(15):2408-2414.
26. Deiner C., Schwimmbeck P.L., Koehler I.S., Loddenkemper C., Noutsias M., Nikol S., et al. Adventitial vegf 165 gene transfer prevents lumen loss through induction of positive arterial remodeling after ptca in porcine coronary arteries. Atherosclerosis 2006, 189(1):123-132.
27. Lahtinen M., Blomberg P., Baliulis G., Carlsson F., Khamis H., Zemgulis V. In vivo h-vegf165 gene transfer improves early endothelialisation and patency in synthetic vascular grafts. Eur J Cardiothorac Surg 2007, 31(3):383-390.
28. Tao Z.X., Chen B., Tan X.A., Zhao Y.M., Wang L.S., Zhu T.B., et al. Coexpression of vegf and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA 2011, 108(5):2064-2069.
29. Khan A.A., Paul A., Abbasi S., Prakash S. Mitotic and antiapoptotic effects of nanoparticles coencapsulating human vegf and human angiopoietin-1 on vascular endothelial cells. Int J Nanomedicine 2011, 6:1069-1081.
30. Liu A.H., Watanabe T., Honma I., Wang J., Zhou H.S. Effect of solution pH and ionic strength on the stability of poly(acrylic acid)-encapsulated multiwalled carbon nanotubes aqueous dispersion and its application for nadh sensor. Biosens Bioelectron 2006, 22(5):694-699.
31. Liu Z., Tabakman S.M., Chen Z., Dai H.J. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Protoc 2009, 4(9):1372-1382.
32. Paul A., Chen G., Khan A., Rao V.T., Shum-Tim D., Prakash S. Genipin-crosslinked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplant 2012, [Epub ahead of print]. http://dx.doi.org/10.3727/096368912X637497.
33. Jiang J., Liu W., Guo X., Zhang R., Zhi Q., Ji J., et al. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene 2011, 30(44):4498-4508.
34. Clerey N., Faurey S., Helesbeux J.J., Duval O., Andriantsitohaina R. Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells. Carcinogenesis 2011, 32(3):286-295.
35. Welt F.G., Edelman E.R., Simon D.I., Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000, 20(12):2553-2558.
36. Worsey M.J., Laborde A.L., Miller B.V., Bower T.R., Landas S., Kresowik T.K., et al. Endovascular canine anastomotic stenting. J Surg Res 1993, 54(1):29-33.
37. Newman K.D., Dunn P.F., Owens J.W., Schulick A.H., Virmani R., Sukhova G., et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995, 96(6):2955-2965.
38. Paul A., Khan A.A., Shum-Tim D., Prakash S. Bacmam virus transduced cardiomyoblasts can be used for myocardial transplantation using AP-PEG-A microcapsules: molecular cloning, preparation, and in vitro analysis. J Biomed Biotechnol 2010, 858094. 10.1155/2010/858094.
39. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H.S., Leon M.B. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998, 31(1):224-230.
40. Schwartz R.S., Huber K.C., Murphy J.G., Edwards W.D., Camrud A.R., Vlietstra R.E., et al. Restenosis and the proportional neointimal response to coronary-artery injury - results in a porcine model. J Am Coll Cardiol 1992, 19(2):267-274.
41. Schwartz R.S., Murphy J.G., Edwards W.D., Camrud A.R., Vlietstra R.E., Holmes D.R. Restenosis after balloon angioplasty - a practical proliferative model in porcine coronary-arteries. Circulation 1990, 82(6):2190-2200.